Meunier 1991.

Methods	Allocation concealment: NA Blinding of study: no Support: Pfizer
Participants	59 participated total Excluded: NA Acute leukaemia, prophylactic
Interventions	Fluconazole: 200 mg/d orally Amphotericin B: 400 mg/d orally + 30 mg/d sucking
Outcomes	Death Infections Use of escape drug Dropouts because of adverse effects
Notes	Follow‐up period (days): 60 Days on fluconazole: 16 Days on amphotericin B: 16.5 Support: Pfizer
Risk of bias
Bias	Authors' judgement	Support for judgement
Allocation concealment (selection bias)	Unclear risk	B ‐ Unclear
Blinding (performance bias and detection bias) All outcomes	High risk